A preliminary data: Evaluation of serum Galectin-3 levels in patients with Idiopathic Parkinson's Disease

ConclusionOur study supports the hypothesis that serum galectin-3 level might be associated with IPD. Our data suggest that serum galectin-3 levels might be an accessible biomarker for the detection and prevention of chronic, progressive diseases such as IPH.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research